We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rejects AstraZeneca’s Bid to Block Mylan’s Generic Nexium
Court Rejects AstraZeneca’s Bid to Block Mylan’s Generic Nexium
The Federal Circuit appeals court has denied AstraZeneca’s effort to block Mylan’s launch of a generic version of the acid reflux blockbuster Nexium, paving the way for additional competition for the drug.